Impax Laboratories Up On FDA Approval (IPXL)

Loading...
Loading...
Impax Laboratories, Inc.
IPXL
is up around 1% in early Wednesday trading after the company received final FDA approval today for generic Doryx 75 and 100mg tablets. At last check, shares of Impax were up 23 cents to $20.73, a gain of 1.1%.
Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...